|
|
| (116 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| | + | |
| | | | |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| − | *'''[[Reviews on covid19 disease]]'''
| |
| | | | |
| | + | *'''[[Reviews on covid19 disease]]''' |
| | *'''[[Clinical guidelines and advice]]''' | | *'''[[Clinical guidelines and advice]]''' |
| − | {{tp|p=32353109|t=ä. COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and Polypharmacy |pdf=|usr=}}
| |
| − | {{tp|p=32343984|t=ä. COVID-19: before stopping specific infection control measures, be sure to exclude the diagnosis |pdf=|usr=}}
| |
| − | {{tp|p=32201156|t=ä. Multiple parameters required for diagnosis of COVID-19 in clinical practice |pdf=|usr=}}
| |
| | | | |
| − | ----
| |
| | | | |
| | | | |
| − | *'''[[Structure of covid19]]''' | + | *'''[[Respiration mgmt]]''' |
| − | {{tp|p=32361692|t=2020. How the COVID-19 Overcomes the Battle? An Approach to Virus Structure |pdf=|usr=}}
| + | |
| − | {{tp|p=32306836|t=2020. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment |pdf=|usr=}}
| + | |
| − | {{tp|p=32145215|t=ä. Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2 |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[Diagnosis (Laboratory)]]''' |
| | | | |
| | | | |
| − | *'''[[Target binding and uptake]]''' | + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| | | | |
| | + | *'''[[Diagnosis (other modalities)]]''' |
| | | | |
| | | | |
| − | *'''[[Cytopathic effects]]'''
| |
| | | | |
| | + | |
| | + | *'''[[Structure of covid19]]''' |
| | + | |
| | + | |
| | + | *'''[[Target binding and uptake]]''' |
| | + | *'''[[Cytopathic effects]]''' |
| | *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Innate sensing]]''' | | *'''[[Innate sensing]]''' |
| | | | |
| | *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| | + | |
| | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| | | | |
| | | | |
| | | | |
| − | ----
| + | *'''[[Pathobiology]]''' |
| | + | |
| | + | |
| | + | *'''[[Disease Models]]''' |
| | + | |
| | + | |
| | + | *'''[[Similar diseases and pathomechanisms]]''' |
| | + | |
| | + | |
| | | | |
| | | | |
| Zeile 44: |
Zeile 56: |
| | *'''[[Co-Infection]]''' | | *'''[[Co-Infection]]''' |
| | | | |
| − | *'''[[ARDS]]'''
| |
| | | | |
| | *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
| − | {{tp|p=32311448|t=ä. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Hematology]]'''
| |
| | | | |
| − | *'''[[Microvascular]]'''
| |
| | | | |
| − | *'''[[Heart]]'''
| |
| − | {{tp|p=32209382|t=ä. The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | *'''[[Hematology]]''' |
| | | | |
| − | *'''[[Neurology, ophthalmology, orl]]'''
| |
| − | *'''[[Dermatology]]'''
| |
| | | | |
| − | *'''[[Gastroenterology, hepatology]]'''
| |
| − | {{tp|p=32363540|t=ä. Bowel Necrosis in the Setting of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32298767|t=ä. COVID-19: Abnormal liver function tests |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Heart]]''' |
| | | | |
| − | *'''[[Kidney, urology]]'''
| |
| | | | |
| − | ----
| |
| | | | |
| | + | *'''[[Neurology, ophthalmology, orl]]''' |
| | | | |
| − | *'''[[Pathobiology]]'''
| |
| − | {{tp|p=32283163|t=ä. A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32348495|t=ä. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19 |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Disease Models]]'''
| |
| | | | |
| − | *'''[[Similar diseases and pathomechanisms]]''' | + | *'''[[Dermatology]]''' |
| − | ----
| + | |
| | | | |
| | | | |
| − | *'''[[Diagnosis (Laboratory)]]'''
| |
| | | | |
| − | *'''[[Diagnosis (Lung CT, Sonography)]]''' | + | *'''[[Gastroenterology, hepatology]]''' |
| | | | |
| | + | *'''[[Kidney, urology]]''' |
| | | | |
| − | *'''[[Diagnosis (other modalities)]]''' | + | *'''[[The morbid survivor]]''' |
| − | {{tp|p=32344326|t=2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[Risk and special populations]]''' |
| | | | |
| − | *'''[[Respiration mgmt]]'''
| |
| − | {{tp|p=32339975|t=2020. Safe bronchodilator treatment in mechanically ventilated COVID-19 patients: A single center experience |pdf=|usr=}}
| |
| − | {{tp|p=32279018|t=ä. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports |pdf=|usr=}}
| |
| − | {{tp|p=32317225|t=ä. A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo, Japan: A case report |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | *'''[[Case reports]]''' |
| | | | |
| | | | |
| − | *'''[[Risk and special populations]]'''
| |
| | | | |
| | | | |
| − | *'''[[The morbid survivor]]'''
| |
| − | {{tp|p=32334770|t=2020. The Need to Include Assisted Living in Responding to the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32222763|t=ä. COVID-19 Through the Lens of Gerontology |pdf=|usr=}}
| |
| − | {{tp|p=32305489|t=ä. Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France |pdf=|usr=}}
| |
| | | | |
| | | | |
| − |
| |
| − |
| |
| − | *'''[[Case reports]]'''
| |
| | | | |
| | *'''[[Case series]]''' | | *'''[[Case series]]''' |
| Zeile 115: |
Zeile 101: |
| | | | |
| | *'''[[Registries]]''' | | *'''[[Registries]]''' |
| − | {{tp|p=32305438|t=ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Trials]]''' | | *'''[[Trials]]''' |
| − | {{tp|p=32290293|t=2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | ----
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | *'''[[Remission, recurrence and persistence]]'''
| |
| − |
| |
| | | | |
| | | | |
| Zeile 142: |
Zeile 112: |
| | | | |
| | *'''[[Biophysics of aerosols]]''' | | *'''[[Biophysics of aerosols]]''' |
| − | {{tp|p=32340347|t=2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough |pdf=|usr=}}
| |
| − | {{tp|p=32360356|t=ä. Putting some context to the aerosolization debate around SARS-CoV-2 |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Passive protective equipment]]'''
| |
| | | | |
| | | | |
| − | *'''[[Running your hospital]]''' | + | *'''[[Passive protective equipment]]''' |
| | | | |
| | | | |
| − | ----
| + | |
| | + | *'''[[Running your hospital]]''' |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − | {{tp|p=32259628|t=ä. Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist |pdf=|usr=}}
| + | |
| − | {{tp|p=32208139|t=ä. Coronavirus Disease 2019 (COVID-19) and Beyond: Micropractices for Burnout Prevention and Emotional Wellness |pdf=|usr=}}
| + | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| | | | |
| | | | |
| | | | |
| − | *'''[[Socio-psychiatric aspects of the status hygienicus]]'''
| |
| − | {{tp|p=32307522|t=ä. Assessing the Impact of the COVID-19 Pandemic and Accompanying Mitigation Efforts on Older Adults |pdf=|usr=}}
| |
| − | {{tp|p=32296840|t=ä. Aging in Times of the COVID-19 Pandemic: Avoiding Ageism and Fostering Intergenerational Solidarity |pdf=|usr=}}
| |
| − | {{tp|p=32282920|t=ä. ?We?re staying at home? Association of self-perceptions of aging, personal and family resources and loneliness with psychological distress during the lock-down period of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32355556|t=ä. Impact of coronavirus outbreak on psychological health |pdf=|usr=}}
| |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| − | {{tp|p=32283124|t=ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| − | {{tp|p=32147406|t=ä. Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China |pdf=|usr=}}
| + | |
| − | {{tp|p=32243947|t=ä. Beyond the assistance: additional exposure situations to COVID-19 for healthcare workers |pdf=|usr=}}
| + | |
| − | {{tp|p=32278703|t=ä. Preventing the Transmission of COVID-19 Amongst Healthcare Workers |pdf=|usr=}}
| + | |
| − | {{tp|p=32278701|t=ä. Knowledge, attitude and practice regarding COVID-19 among health care workers in Henan, China |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − | {{tp|p=32325710|t=2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response |pdf=|usr=}}
| |
| − | {{tp|p=32305533|t=ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review |pdf=|usr=}}
| |
| − | {{tp|p=32292707|t=ä. Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 192: |
Zeile 147: |
| | | | |
| | *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
| − | {{tp|p=32277970|t=ä. Strategies to trace back the origin of COVID-19 |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Epidemiology]]''' |
| | | | |
| | | | |
| − | *'''[[Epidemiology]]'''
| |
| | | | |
| | | | |
| | | | |
| | + | *'''[[Remission, recurrence and persistence]]''' |
| | | | |
| − | *'''[[Failure of politics and public health guidance]]'''
| |
| − | {{tp|p=32373315|t=ä. The need to improve the laws and regulations relevant to the outbreak of COVID-19: What might be learned from China?|pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| | ---- | | ---- |
| | + | *'''[[Failure of politics and public health guidance]]''' |
| | | | |
| | | | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| − | {{tp|p=32316647|t=2020. Using Social Media to Mine and Analyze Public Opinion Related to COVID-19 in China |pdf=|usr=}}
| + | |
| − | *[https://www.businessinsider.com/nearly-half-of-reopen-america-twitter-accounts-are-bots-report-2020-5?utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter twitter botwar]
| + | |
| − | *[https://www.frontpagemag.com/point/2020/05/obama-clinton-9th-circuit-judges-suspend-bill-daniel-greenfield/ judges declare the Bill of Rights is suspended until the Coronavirus is cured]
| + | |
| − | *[http://freerepublic.com/focus/f-news/3848303/posts They want you divided, and focused on other enemies.]
| + | |
| | | | |
| | | | |
| | *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
| − | {{tp|p=32142979|t=2020. Li Wenliang, a face to the frontline healthcare worker The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32271208|t=ä. Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People?s Republic of China |pdf=|usr=}}
| |
| − | {{tp|p=32277966|t=ä. Characteristics of deaths amongst health workers in China during the outbreak of COVID-19 infection |pdf=|usr=}}
| |
| | | | |
| | *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| | + | |
| | ---- | | ---- |
| | | | |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | {{tp|p=32120913|t=2020. Epidemiological Identification of A Novel Pathogen in Real Time: Analysis of the Atypical Pneumonia Outbreak in Wuhan, China, 2019?2020 |pdf=|usr=}}
| + | *'''[[misc.]]''' |
| − | {{tp|p=32001309|t=2020. Emergence of a novel coronavirus causing respiratory illness from Wuhan, China |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[misc.]]'''
| |
| | *'''[[Research tools]]''' | | *'''[[Research tools]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | + | |
| | + | *'''[[PrePrint scene]]''' |
| | + | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| − | *[lifechemicals.com antiviral candidate drugs]
| |
| − | *[biomol.com assays cytokines general spectrum]
| |
| − | *[labospace.com custom single probe assay 400 possible cytokines and so on]
| |
| − | *[codexdna.com dna synthesis]
| |
| − | *
| |
| | | | |
| | *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| | + | *'''[[on-topic personal thoughts]]''' |
